BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32252933)

  • 1. Venoocclusive Disease With Both Hepatic and Pulmonary Involvement.
    Tissot N; Montani D; Seronde MF; Degano B; Soumagne T
    Chest; 2020 Apr; 157(4):e107-e109. PubMed ID: 32252933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease.
    Günther S; Perros F; Rautou PE; Girerd B; Ghigna MR; Cazals-Hatem D; Lau EM; Dorfmüller P; Sitbon O; Valla DC; Humbert M; Montani D
    Am J Pathol; 2019 Jun; 189(6):1159-1175. PubMed ID: 30926335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Veno-occlusive Disease that Developed Following Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
    Takeda K; Naito A; Sugiura T; Ishige M; Shikano K; Abe M; Kasai H; Miyakuni S; Yamashita S; Shigeta A; Sakao S; Suzuki T
    Intern Med; 2023 Jan; 62(2):275-279. PubMed ID: 35705278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Pulmonary Veno-occlusive Disease Following Hepatic Veno-occlusive Disease After Autologous Hematopoietic Stem Cell Transplantation for Neuroblastoma.
    Isshiki K; Shima H; Yamazaki F; Takenouchi T; Shimada H
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e677-e679. PubMed ID: 31335821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted therapy in pulmonary veno-occlusive disease: time for a rethink?
    Luo Q; Jin Q; Zhao Z; Zhao Q; Yu X; Yan L; Zhang Y; Xiong C; Liu Z
    BMC Pulm Med; 2019 Dec; 19(1):257. PubMed ID: 31856792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound in Hepatic Veno-occlusive Disease (HVOD) after Pediatric Hematopoietic Stem Cell Transplantation (HSCT): Comparison of Diagnostic Criteria Including the Pediatric Criteria of European Society for Blood and Marrow Transplantation (EBMT).
    Chung H; Im SA; Kim SK
    Pediatr Hematol Oncol; 2020 May; 37(4):275-287. PubMed ID: 32131664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality.
    Kashyap A; Wingard J; Cagnoni P; Roy J; Tarantolo S; Hu W; Blume K; Niland J; Palmer JM; Vaughan W; Fernandez H; Champlin R; Forman S; Andersson BS
    Biol Blood Marrow Transplant; 2002; 8(9):493-500. PubMed ID: 12374454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients: A case report.
    Zhang L; Wang Y; Zhang R
    Medicine (Baltimore); 2021 Oct; 100(41):e27334. PubMed ID: 34731104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction.
    Bunte MC; Patnaik MM; Pritzker MR; Burns LJ
    Bone Marrow Transplant; 2008 Apr; 41(8):677-86. PubMed ID: 18223697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C.
    Certain MC; Chaumais MC; Jaïs X; Savale L; Seferian A; Parent F; Georges M; Favrolt N; Bourdin A; Boissin C; Cottin V; Traclet J; Renard S; Noel V; Picard F; Girerd B; Ghigna MR; Perros F; Sitbon O; Bonniaud P; Humbert M; Montani D
    Chest; 2021 Mar; 159(3):1197-1207. PubMed ID: 32979348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic sinusoidal obstruction syndrome following hematopoietic stem cell transplantation.
    Krimmel T; Williams LA
    Oncol Nurs Forum; 2008 Jan; 35(1):37-9. PubMed ID: 18192151
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylaxis and treatment recommendations for sinusoidal obstruction syndrome in adult and pediatric patients undergoing hematopoietic stem cell transplant: a review of the literature.
    Hopps SA; Borders EB; Hagemann TM
    J Oncol Pharm Pract; 2016 Jun; 22(3):496-510. PubMed ID: 26126501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances.
    Nassereddine S; Alsubait S; Tabbara I
    Anticancer Res; 2018 May; 38(5):2597-2605. PubMed ID: 29715079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
    Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: pulmonary veno-occlusive disease: a rare but fatal cause of pulmonary hypertension in a patient following allogeneic stem cell transplantation.
    Katrien M; Dieter S; Anke D; Amelie D; De Pauw M; Eric D
    Acta Clin Belg; 2022 Jun; 77(3):697-702. PubMed ID: 34191691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic cell transplantation in systemic mastocytosis: is there a high risk for veno-occlusive disease?
    Ustun C; Smith A; Cayci Z; Courville EL; Corbacioglu S; Akin C; Horny HP; Valent P; Devine S; Weisdorf DJ
    Eur J Haematol; 2016 Jun; 96(6):655-7. PubMed ID: 26679533
    [No Abstract]   [Full Text] [Related]  

  • 19. Interplay of Inflammation and Endothelial Dysfunction in Bone Marrow Transplantation: Focus on Hepatic Veno-Occlusive Disease.
    Vion AC; Rautou PE; Durand F; Boulanger CM; Valla DC
    Semin Thromb Hemost; 2015 Sep; 41(6):629-43. PubMed ID: 26305238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallbladder wall oedema and ascites are independent predictors of progression to hepatic veno-occlusive disease for children with hematopoietic stem cell transplantation.
    Park JE; Choi YH; Cheon JE; Kim WS; Kim IO; Ryu YJ; Kim YJ; Hong CR; Kang HJ
    Eur Radiol; 2018 Jun; 28(6):2291-2298. PubMed ID: 29294155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.